Lion’s Mane Mushroom: Why This Shaggy Fungus Is Everywhere in Brain Wellness

Lion’s Mane, or Hericium erinaceus, is easy to recognize: a white, rounded mushroom covered in soft, dangling spines. It grows on hardwood and has long been used in East Asian food and traditional practices; in some cuisines, it is eaten cooked for its tender texture and savory, umami flavor.
Its growing presence in brain-wellness products has a more specific rationale than a general “functional mushroom” trend. Researchers have studied compounds associated with Lion’s Mane for their potential nerve-related activity. But a plausible mechanism is not proof of a benefit in people, and the human evidence remains limited.
Why Lion’s Mane Draws Brain-Wellness Interest
Two groups of compounds often appear in discussions of Lion’s Mane: hericenones, associated primarily with the mushroom’s fruiting body, and erinacines, associated primarily with its mycelium. Preclinical studies have examined whether some of these compounds affect nerve growth factor (NGF), a protein involved in the development and maintenance of certain nerve cells.
That research offers a reason for scientific interest, not a clinical promise. Findings from cells or animal models cannot establish that an orally consumed supplement increases NGF in a person’s brain, “grows new brain cells,” or improves memory. Those consumer-facing claims go beyond what the evidence can show.

What Human Studies Have, and Have Not, Found
The often-cited clinical trial in older adults enrolled 30 people aged 50–80 with mild cognitive impairment. Participants took 3 grams per day of mushroom powder for 16 weeks. Cognitive scores improved relative to placebo at several assessments during the study, but the scores declined after the participants stopped taking the powder, during a four-week follow-up. The trial was small and short, and its result does not establish prevention or treatment of dementia. Read the trial abstract.
Research in healthy adults is also limited. A small 2023 pilot study tested both acute and 28-day use in healthy younger adults. Its findings were mixed: some measures showed possible effects, while other results were not conclusive. Such early studies help shape future research; they do not establish a reliable cognitive benefit for the general public. Read the study.
A study that may be of interest to women in midlife examined 30 women with menopausal or perimenopausal-type complaints. For four weeks, participants consumed cookies containing either Lion’s Mane fruiting-body powder or placebo. The active group received 2 grams per day. After exclusions, 26 participants were included in the analysis. Some mood and general-complaint scores improved within the Lion’s Mane group, but the study did not demonstrate a clear, consistent advantage over placebo. It did not establish Lion’s Mane as a treatment for depression, anxiety, menopause symptoms, or cognitive changes. Read the study.
Overall, the number of human trials is small, the preparations and study designs vary, and follow-up is generally brief. Reviews have characterized the evidence as limited or low quality. No standard supplemental dose has been established. The amounts used in individual studies should be understood as study protocols, not as dosing recommendations for consumers.
Fruiting Body, Mycelium, and Extraction Matter
For product developers, “Lion’s Mane” is not a complete material specification. A product may use fruiting body, mycelium, or a blend, and those materials are not interchangeable by default. Fruiting body is the relevant source when a formulation rationale centers on hericenones; mycelium is the relevant source when it centers on erinacines. Actual content can vary with strain, growing conditions, processing, and the finished ingredient.
The preparation also affects what a product delivers. A whole-mushroom powder and a hot-water extract are different materials, and extraction can change the concentration and profile of constituents. A label or supplier specification should make the material and process clear rather than relying on a broad mushroom name alone.
Mycelium grown on grain deserves particular scrutiny. If grain substrate remains in the finished powder, the material may contain substantial starch rather than concentrated fungal biomass. That does not mean every mycelial ingredient is poor quality; it means that substrate and composition should be disclosed and verified.

Quality Checks for Supplement Brands
A methodical ingredient review can help brands assess identity, consistency, and suitability for their intended formulation. Useful questions include:
- Is the species confirmed as Hericium erinaceus?
- Does the ingredient use fruiting body, mycelium, or both, and is the substrate disclosed?
- Is the product a powder or an extract, and is the extraction method described?
- Are beta-glucans measured separately from total polysaccharides?
- Is starch or alpha-glucan content tested to help identify grain-heavy material?
- Are identity and contaminant tests available, including testing for heavy metals, pesticides, microbes, and mycotoxins?
Beta-glucan content can serve as one quality indicator, but it does not establish a cognitive effect. Assay method matters: nonspecific “total polysaccharide” figures may not distinguish fungal beta-glucans from grain starch. If an ingredient is marketed around erinacines, a quantitative assay for those compounds is more informative than an unsupported general claim about NGF.

Taste and delivery format also require attention. Lion’s Mane can have earthy, savory or umami notes that may be more noticeable in powders and gummies than in capsules. Prototype work can help assess flavor, texture, ingredient compatibility, and serving size before a product is finalized.
Claims and Safety Considerations
In the United States, supplement marketing must be truthful, substantiated, and compliant with applicable rules. A carefully qualified structure/function statement, such as “supports cognitive health”, still requires appropriate substantiation and must not imply disease treatment or prevention. Claims that Lion’s Mane prevents or treats Alzheimer’s disease or dementia are not supported by the small, limited evidence described here. Nor should preclinical NGF findings be translated into consumer promises that a product “grows new brain cells.”
Lion’s Mane was generally well tolerated in the small, short human studies, though gastrointestinal discomfort and other mild effects have been reported; a skin rash has also been reported rarely. The available trials are not large or long enough to establish long-term safety. People with mushroom allergies should avoid assuming the ingredient is suitable. Anyone who is pregnant or breastfeeding, managing a health condition, or taking medication should consult a qualified health professional before use. This includes people taking anticoagulants: interaction concerns are theoretical and not well established, but medication-specific review is prudent.
A Promising Ingredient, Not a Proven Brain Remedy
Lion’s Mane has a distinctive food history, an interesting preclinical research profile, and a handful of small human studies. Those features justify continued investigation, but they do not amount to proof of durable cognitive support or disease prevention. For consumers, the distinction between preliminary research and established benefit matters; for brands, transparent material specifications, sound testing, and restrained claims matter just as much.
For businesses exploring a Lion’s Mane product, SolisLabs’ R&D formulation process covers ingredient selection, dosage research, prototyping, and product development. SolisLabs is a GMP-certified, USA-based manufacturing partner offering support from formulation through packaging.

